Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register shares directly so shorts cant get them.
However, the trend into direct registration—in some ways, the equivalent of a Gen Xer’s late-teen child finding their Sony DiscMan hidden in a an old briefcase and deciding that this was the pinnacle of music technology—started weeks ago as self-professed ‘Apes’ realized after January that using zero-commission trading apps didn’t mean they were buying stock in a company, but were instead paying a broker to hold their stock via a “street name.”
It didn’t take long thereafter for those Apes to decide that this sort of indirect ownership was fueling short sellers, who borrow shares and create the kind of synthetic trading environment that some retail investors believe has allowed hedge funds and other institutions to execute shorts and avoid the pain of being squeezed themselves.
“In the last few weeks, we’ve seen a significant increase in direct registration transactions in some U.S.-listed ‘meme-stocks’,” Paul Conn, Computershare’s president of Global Capital Markets, told MarketWatch’s MemeMoney.
“Retail investors have asked their broker or bank to remove their investments from the ‘street name’ system and into their own name directly onto the company’s share register,
https://www.marketwatch.com/story/the-reddit-crowd-has-found-a-new-tactic-in-the-war-against-wall-street-cutting-brokers-out-altogether-11634250783?siteid=yhoof2
But for Reddit’s retail Apes, there is one other huge perk to direct registration in meme stocks: keeping brokers, short sellers and market makers from creating a condition in which the amount of shares sold short in any given company exceed the total amount of shares outstanding. So-called naked shorting, where investors profit from bets on stock without owning it is illegal on Wall Street, but many Redditors believe that naked shorting is alive and well due in part to indirect ownership. Short bets are inherently risky because losses on a wrongway wager can be infinite.
“When the music stops, there aren’t enough shares to go around,” said Susanne Trimbath, CEO of STP Advisory Services, and an economist who has been a key voice in educating retail investors on market structure.
“These retail investors are trying to stop the music.”
America's Cannabis Industry Evolution Is Being Shoved Underground by Lack of Banking Infrastructure
https://www.benzinga.com/markets/cannabis/21/10/23381314/americas-cannabis-industry-evolution-is-being-shoved-underground-by-lack-of-banking-infrastructu
The cannabis industry has never stopped evolving as state-by-state adult-use legalization has taken place at a breakneck pace; however, common business tools such as banking solutions still remain elusive for many canna-businesses. In fact, the slow rate of mainstream banking adoption has threatened to slow the progress of legitimizing the cannabis industry, and has actually begun to shove the industry underground as desperate business leaders search for ways to decrease their risk, increase employee and consumer safety, and reduce opportunities for fraud. Unfortunately, a failure to act may have even caused an increase in illicit markets.
This issue is not new, but its importance is more crucial now than ever before. Legalized cannabis has existed for nearly nine years in states like Washington and Colorado. In 2021, the cannabis industry is beginning to burst at its seams and the rally cry grows louder for banking reform. As Bloomberg reported: “[the cannabis industry’s] evolution is being handicapped by a lack of basic banking infrastructure … While logistical issues facing dispensaries are well known, obstacles to setting up the most basic of commercial operations extend far afield, hobbling scores of vendors and service providers who could help the industry emerge from the shadows.” This was reported in 2016. Five years later, the situation is more desperate than before, and this issue remains top of mind.
Gaining Freedom From the Cash-Based Business Model
Recently, the U.S. House of Representatives voted to approve a large-scale defense bill that included a key amendment: banks could be protected from the risks of working with cannabis businesses with a license and full compliance in their state. As Rep. Ed Perlmutter (D-CO) explained: “This will strengthen the security of our financial system in our country by keeping bad actors like foreign cartels out of the cannabis industry. But most importantly, this amendment will reduce the risk of violent crime in our communities. By dealing in all cash, these businesses and their employees become targets for robberies, assaults, burglaries, and more.”
The fear of being punished by federal regulators is a very real aspect bankers are concerned about as cannabis remains a Schedule 1 drug. Despite the legal status of adult-use cannabis across U.S. states, regulations are often in flux, leading to either the lack of staffing to properly understand the rules, or an inability to keep up on changes as they happen. In short – the apparent risk of banking with cannabis companies remains too high for many banking institutions to accept.
The Lack of Traditional Banking Services Hinders Cannabis Industry Growth
There are several major issues faced by cannabis businesses who are accruing profit from their customers in a cash-based environment. Not only is it difficult to find a bank that will offer its services, but when they do, banking often comes with high fees in order for the banks to mitigate any potential risks or damages and additional overhead costs.
With a system lacking universal compliance and regulations varying state-by-state, there are often bad actors or the beginnings of an environment ripe with fraud. Legal, state-certified cannabis companies are often seeking ways to increase transparency in their businesses, and while they are largely able to establish pillars of transparency like being an upstanding employer, donating to local social programs, and innovating with environmentally friendly business practices like eco-packaging or waste reduction, they are often left with few options to remain transparent in a very crucial aspect of their business: point of sale purchases and banking. While some do their best with limited tools and resources, some take the opportunity to exploit loopholes or grey areas, which can lead to full-blown fraud in the market.
Even with business leaders who have the best of intentions, the lack of banking availability means state regulators are also missing a valuable opportunity to provide oversight and checks and balances to the system.
Solutions Are Needed Today – And They Already Exist
Until the United States government enacts true reform, several solutions exist for cannabis companies to remain compliant and access necessary banking resources. From solutions like gift cards to mobile wallets or loyalty programs that track purchases, there is no shortage of innovative individuals and companies trying to offer solutions to this problem.
Anyone in the cannabis industry can tell you, we have proven ourselves to be made up of inventive, dedicated, and resilient individuals, and that has never been more apparent than when it comes to banking. We remain hopeful for country-wide reform and until then, we keep innovating daily to build up this industry and work even further toward mainstream legitimacy.
No worries not that anyones worried. Other companies would also like to know. When playing hands are kept close to vest no one else knows whats what including us.
Don't know, or the spider is heeling a few degrees to the green starboard side been red such a dog gone long time the politics of cannabis and our government is a decades long farce Let there be Peace on Cannabis this holiday season Joe Biden boss hog wanabe got yer ears on bad buddy?
Not close. On 30 Sept 2018 there were 93 million shares outstanding.
Aug 2021 there were 140 M sh out there.
Aug. 10, 2021 140.34M
June 30, 2021 140.16M
May 10, 2021 139.88M
March 31, 2021 139.87M
March 22, 2021 139.81M
Dec. 31, 2020 139.53M
Nov. 9, 2020 139.08M
Sept. 30, 2020 138.97M
Sept. 11, 2020 138.97M
June 30, 2020 138.79M
June 18, 2020 138.77M
June 15, 2020 127.27M
May 13, 2020 108.93M
March 31, 2020 108.62M
March 23, 2020 108.43M
Jan. 1, 2020 105.56M
Dec. 31, 2019 103.72M
Dec. 3, 2019 103.78M
Dec. 2, 2019 98.78M
Nov. 22, 2019 98.78M
Nov. 12, 2019 98.59M
Sept. 30, 2019 97.90M
Aug. 12, 2019 97.47M
July 29, 2019 97.36M
June 30, 2019 97.36M
June 17, 2019 97.36M
May 24, 2019 95.10M
March 31, 2019 93.25M
Dec. 31, 2018 93.17M
Sept. 30, 2018 93.11M
Please share how thats so. Preferably with links as reference.
United nations old news from 2020 when pied piper Trump was boss hog of the universe,,,,,,,,
Among WHO’s recommendations, it was suggested that cannabidiol (CBD) with 2 percent or less Tetrahydrocannabinol (THC, the addictive substance) should not be subject to international controls. Member States rejected that recommendation for a variety of reasons, including some Member States arguing that CBD is not currently under international control and there was, thus, no need for action. CBD has taken on a prominent role in wellness therapies in recent years, and sparked a billion-dollar industry.
Meanwhile, the United States voted to remove cannabis from Schedule IV of the Single Convention while retaining them in Schedule I, saying it is “consistent with the science demonstrating that while a safe and effective cannabis-derived therapeutic has been developed, cannabis itself continues to pose significant risks to public health and should continue to be controlled under the international drug control conventions”
2 December 2020 In reviewing a series of World Health Organization (WHO) recommendations on cannabis and its derivatives, the Commission on Narcotic Drugs (CND) zeroed-in on the decision to remove cannabis from Schedule IV of the?1961 Single Convention on Narcotic Drugs?— where it was listed alongside specific deadly, addictive opioids, including heroin, recognized as having little to no therapeutic purposes.
So why is cannabis still schedule one in America land of the incarcerated home of the non brave,,, afraid of Gods Plant Cannabis? Nah ya can control the world fighting plants. Bogota Columbia in 1950 was a wonderful city along with hundreds of others till wars on plants commenced all over the world except in communist countrys. So we fight communism so can go in there looking for illegal plants one way or the other. This crap has destroyed the world. Made refugee out of all. Roosters come home to roost.
https://news.un.org/en/story/2020/12/1079132
GRAS is Greener When Legally Confirmed
Last week, the legality of the self-affirmed GRAS (Generally Recognized As Safe) framework – known popularly as “self-GRAS” -- was confirmed by a federal court. Self-GRAS allows companies that have self-determined the safety of their food ingredients to be exempt from pre-market review by FDA, based on reviews by independent, qualified expert panels. When used in the food supply, these ingredients also qualify for exemption from the New Dietary Ingredient notification (“NDIN”) requirements for dietary supplements. Problems with a mandatory NDIN-only approach were brought to light recently when two comprehensive and science-driven NDINs for hemp extract ingredients were rejected by the FDA.
This court decision is great news for CBD companies that have already invested substantial resources to establish the safety of their products through self-GRAS. More importantly, it reinforces the importance of congressional efforts – through HR 841 and S 1698 -- to allow CBD companies to have access to all of the same safety pathways provided to other dietary supplements and food and beverage ingredients.
Help us realize our mission to Regulate CBD Now. Go to regulateCBDnow.com and urge your Members of Congress to Stop the Stalemate and Regulate CBD Now!
https://www.regulatecbdnow.com
Biden ought to direct his staff to write up legalization paperwork and pencil whip it with executive order in order his federal agents wont have to enforce cannabis laws hopping on trains getting into shootouts dying when should be living life earning a paycheck fighting real crime. Jeeeeeeez my tax dollars wasted on enforcement of outdated by decades unjust laws set forth against this plant thats grown wild for millions of years all over this earth hurting no one. Biden must like prohibition to control the worlds populace as does the UN who also enforces. Amtrak likes prohibition and shootouts makes for great news. They started this crap episode are responsible for another lawman and young man dying. The war on people continues.
TUCSON, Ariz. (AP) — Officials on Thursday identified the armed passenger who died in a gunfight after fatally shooting a federal agent inside an Amtrak train in Arizona as Darrion Taylor.
The Pima County Medical Examiner’s Office in Tucson said in a news release that Taylor, 26, was shot in the torso and limbs.
The wounds were not self-inflicted, according to medical examiner Dr. Gregory Hess. A more detailed autopsy will be completed sometime next month.
A regional task force of Drug Enforcement Administration agents and local police officers were inspecting baggage for contraband at the train station in downtown Tucson on Monday morning.
The train they were screening was the Sunset Limited, Train 2. It was making a scheduled stop in Tucson after leaving Los Angeles for New Orleans, according to Amtrak officials.
Acting on tips from Amtrak, authorities say they got permission to search baggage belonging to Taylor and another passenger in the same row, Devonte Okeith Mathis. When an officer found two bulk packages of marijuana during an inspection on the platform, Michael Garbo, a DEA group supervisor, and another agent reentered a train car to talk to Taylor.
Authorities say that's when Taylor opened fire, killing Garbo and wounding a second agent. Another Tucson police officer was also caught in the gunfire and wounded.
The agent and officer both remain hospitalized. Their names have not been released.
Tucson police say several responding officers exchanged gunfire with Taylor, who barricaded himself in a bathroom. He was later found dead inside.
Mathis, meanwhile, was arrested on suspicion of knowingly and intentionally possessing with the intent to distribute less than 50 kilograms (110 pounds) of a mixture or substance containing a detectable amount of marijuana.
Victoria Brambl, a federal public defender listed as Mathis' attorney, did not immediately return a voicemail message seeking comment Thursday.
A public funeral for Garbo, who joined the DEA in 2005, is planned for Friday in Tucson.
Charlotte's Web CEO Says Road To Federal Cannabis Legalization Must Start With CBD Regulation
Nina Zdinjak
Thu, October 7, 2021, 8:59 AM
Charlotte's Web Holdings Inc. (OTCQX: CWBHF) CEO Deanie Elsner discussed the hemp CBD extract company’s development, future plans and mission during the last iteration of the Benzinga Cannabis Capital Conference, which is returning to a live format next week in New York City.
In order to build its infrastructure, the company made many important moves last year, the CEO said.
Those include the acquisition of Abacus Health Products Inc. and obtaining organic certification, product patents and B Corp certification, Elsner told panel moderator JJ McKay, founder and publisher at The Fresh Toast.
“A lot of our focus in 2021 and 2022 will be evolving our footprint and expanding our presence across the country or across the globe. We're entering a number of new countries," she said.
Charlotte's Web recently announced cultivation in Canada, and the CBD company has a partnership in Israel and plans to expand into Europe, Elsner said.
The famed Benzinga Cannabis Capital Conference will gather industry insiders and investors from around the world once again on October 14 and 15 in New York City. Attendees can expect two full days of keynotes, panel discussions, fireside chats, networking, company presentations, celebrity appearances and an impressive lineup of the top journalists in the cannabis space.
Charlotte's Web CEO On The US CBB, THC Markets
Cannabis legalization efforts in the U.S. are further along than Elsner expected, she told the Benzinga conference, with around half of states providing legal access to either medical or adult-use cannabis.
The CEO said she anticipates seeing federal legalization in the next three to five years.
"There's a segment opening up in cannabis. It's not just medical marijuana."
That segment is personal wellness, with a focus on higher levels of THC than what is seen in CBD products, and with products targeting anxiety, depression insomnia, pain and inflammation, she said.
Charlotte's Web CEO Says Focus On Transparency, Traceability
What makes Charlotte’s Web stand out is the complete transparency and traceability of their products, Elsner said.
The company is vertically integrated, which means it is producing its own seeds, extracting its own biomass and has no ingredients purchased from other sources, the CEO said.
“What that has enabled us [to do] is become the world's most trusted hemp extract company.”
Those dynamics give Charlotte's Web a strong foundation to enter the cannabis space, as 50% of consumers want to move into cannabis, she said.
The first thing that should be done is to get CBD regulated, with medical and recreational cannabis regulated next, in Elsner's view.
That’s the framework to regulate cannabis, the CEO said.
Elsner On Cannabis As Consumer Packaged Goods Product
With consumers dictating the development of the industry, Elsner said that the cannabis sector is going to move into the consumer packaged goods category.
Consumers are coming via CBD but quickly transitioning to cannabis, the CEO said — for personal wellness reasons.
"And so, Charlotte's Web is in a position to be the bridge between CBD and cannabis wellness, and that category expands our total available market by three to four time
Thanks man, all this news has been so great do not even care never got in a buy in the ones on our favorite little ity bitty spider that in time grows humongous 1/4 by 1/4....................
Thats true for Ca. Then multiply that when other states once get on track.
Notice all the negative mind game news this week in concern cannabis leads to all these horrible maladies of the brain as if weed were like pharma's pills? No comparison. Weed targets the pain, pills target the brain. Pill mills promoting all these articles most likely........ If were to go figure.
Charlotte’s Web’s mission is ‘To unleash the healing powers of botanicals with compassion and science, benefitting the planet and all who live upon it.”
We celebrate state-level progress and believe it underscores the ongoing need for clear, federal regulation of Hemp CBD from Congress and the Administration. We will continue lending our voice and resources to measures that will ensure a safe, credible, and sustainable industry, such as House of Representatives Bill 841 which deserves a hearing in the Energy & Commerce Committee by year’s end. """""SCREAMS CATALYST;;;;;;;;;;;;;
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Denver, Colorado, is the market leader in innovative whole-plant hemp extract wellness products under a family of brands which includes Charlotte’s Web™, CBD Medic™, CBD Clinic™, and Harmony Hemp™. Charlotte’s Web branded premium quality products start with proprietary hemp genetics that are 100-percent American farm grown and manufactured into whole-plant hemp extracts?containing?naturally occurring?phytocannabinoids?including cannabidiol (“CBD”}, CBC, CBG, terpenes,?flavonoids,?and other beneficial hemp compounds.?The Company’s CW Labs R&D science division?is?located?at the University at Buffalo in New York which is part of the State University of New York (SUNY) system of 64 universities.?Charlotte’s Web product categories?include full spectrum hemp extract oil tinctures (liquid?products),?gummies (sleep, stress, inflammation recovery), capsules,?CBD topical creams and lotions, as well as?products for dogs. Charlotte’s Web products are distributed to more than 14,000 retail doors and 8,000 health care practitioners, and online through the Company’s website at www.charlottesweb.com.
Ania with todays news some shorts may know what they are doing by starting covering episodes.
Looks like getting any shares down in the one somethings late next week will be a no go. If California were a lone country it would be a big one as per GDP. Great news today.
Bravo! Good for you Ania. What a gift! Would love to have a great buy in the one somethings to bring cost down into the 2's before masses start breaking the levee average cost so far $3.44 about a double from here. Be a few weeks before have some jing to get more shares tax selling might keep it in here til then unless shorts read my post and cover screwing me up.
Big spider eaters look for little spiders to buy out at premium.
GOP Pennsylvania Senator With Federal Law Enforcement Background To File Marijuana Legalization Bill
https://www.marijuanamoment.net/gop-pennsylvania-senator-with-federal-law-enforcement-background-to-file-marijuana-legalization-bill/
A Republican Pennsylvania senator and former federal law enforcement agent announced on Monday that he will be filing a bill to legalize marijuana in the state—and he’s asking his colleagues to join him in the effort.
Sen. Mike Regan (R), who chairs a key committee with jurisdiction over law enforcement issues, characterized legalization as “inevitable” and is circulating a cosponsorship memo to build support for the forthcoming measure. Before taking office, he served as a U.S. marshal, making it all the more notable that he’s taking this step to end criminalization and enact a system of regulated cannabis sales for adults.
“I had the opportunity to work in federal law enforcement at the height of the drug war, so I know the seriousness of drug use,” Regan wrote. “But I am also cognizant that there has been a significant decline in arrests and prosecutions for personal use amounts of marijuana in recent years.”
“Our law enforcement agencies and justice system do not have the manpower or time to handle these minor marijuana offenses that clog our courts and produce little return,” he said. “Instead, police and prosecutors need to focus on protecting our residents from the violent criminals and large-scale drug importers that are also dealing in heroin and fentanyl, which kill thousands of Pennsylvanians each year.”
Given the senator’s law enforcement credentials and relationships with GOP colleagues who have been historically resistant to Democratic-led pushes for legalization, Regan’s move could help shift the conversation in the legislature.
Good points well made. Prematurely added to position at $2.33 screwing up the rule its best to wait for returns of heavy volumes as indicator when reverses direction from bear to bull.......... Now scratching up more ammo, should already have for were it not for last buy. A buy that hopefully worked but did not, none have so far to date for me or anyone. Stock aggravates to say the most.
WASHINGTON, D.C. - September 30, 2021 (Investorideas.com Newswire) On Thursday, the House Judiciary Committee approved a bill that would remove cannabis from the schedule of controlled substances and end the state-federal conflict that currently exists in the majority of states which have regulated cannabis in some fashion. The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, or H.R. 3617, was reintroduced by House Judiciary Chairman Jerrold Nadler (D-NY) and has 74 cosponsors.
In addition to removing cannabis from the Controlled Substances Act, the bill would expunge non-violent federal cannabis convictions and support state efforts to do the same, provide opportunities and resources for cannabis businesses owned by women and people of color, create reinvestment programs for communities that have been adversely impacted by prohibition, improve immigration laws related to cannabis, and allow doctors in the Veterans Affairs system to recommend medical cannabis to their patients.
The MORE Act was originally approved in a full House vote in December 2020, becoming the first bill to end federal prohibition to pass in either chamber. A companion bill was introduced in the Senate by now-Vice President Kamala Harris, but did not receive a hearing before the end of the session.
The current legislation must be considered or waived by several more committees of jurisdiction before it can be brought up for another floor vote.
"We are thankful that the House continues to pursue sensible cannabis policy reforms and is once again moving on this important bill," said Aaron Smith, co-founder and chief executive officer of the National Cannabis Industry Association (NCIA). "While the MORE Act lacks the robust regulatory structure we would like to see in a comprehensive descheduling bill, it represents the increasing support for ending prohibition among both lawmakers and the American public, not to mention the current policies of dozens of states around the country."
https://www.investorideas.com/news/2021/cannabis/09301End-Federal-Cannabis-Prohibition.asp
Legalization is where it is at , The U.S. House Judiciary Committee on Thursday advanced the sweeping social justice-focused marijuana legalization bill known as the MORE Act in a first step toward passage in the full House.
But the Senate remains the high hurdle.
The Judiciary Committee approved the legislation in a 26-15 vote, with 24 Democrats joined by two Republicans voting yes and 15 Republicans voting no.
The House passed a similar version of the legislation by a 228-164 vote in early December.
The Senate didn’t take up the bill, however, so the process had to be started from scratch by the new Congress, which was seated in January.
Thursday’s vote comes a week after the full House passed a defense budget bill that includes landmark legislation to make it easier for banks to serve cannabis businesses.
Yet like the MORE Act, it appears a long shot that the U.S. Senate will follow suit and approve some form of the SAFE Banking Act.
‘More than symbolic’
Morgan Fox, media relations director for the Washington DC-based National Cannabis Industry Association, said he expects the full House to pass the MORE Act again, and doing so “is definitely more than symbolic.”
“It continues the conversation about figuring out the best way to deschedule and deregulate cannabis. It increases the momentum for comprehensive marijuana reform across the board and in both chambers,” Fox said.
And, in terms of strategy, he said, it provides industry groups and lobbyists information about which lawmakers are on the fence or opposed to marijuana reform and what might be done to address their concerns.
“We’re encouraged to see that the MORE Act is once again advancing in the U.S. House of Representatives,” Matt Schweich, deputy director of the DC-based Marijuana Policy Project, said in a statement.
“We cannot achieve meaningful and lasting criminal justice reform in our country without ending the war on cannabis. Lawmakers on both sides of the aisle have the opportunity and responsibility to come together and pass legislation to finally put an end to the decades-long failure that is federal cannabis prohibition.”
The MORE Act – formally known as the Marijuana Opportunity Reinvestment & Expungement Act – would legalize MJ federally by removing the plant from the federal Controlled Substances Act.
Such legalization would generate new market opportunities but also likely accelerate a commoditization of marijuana that would favor low-cost production areas, which could disrupt the current patchwork of state-legal MJ markets.
Will Senate be a roadblock?
The more conservative Senate still is seen as the biggest obstacle to comprehensive marijuana reform.
Senate Majority Leader Chuck Schumer is leading an effort to promote a similarly sweeping marijuana reform measure called the Cannabis Opportunity and Administration Act.
But it’s unclear if the Senate will take up that measure before next spring, and 60 out of 100 votes likely would be required for passage.
One of the main differences between the MORE Act and Schumer’s proposed bill is taxation.
MORE sets a national retail tax rate of 5% on marijuana product sales for the first two years, gradually increasing to 8%.
The draft Cannabis Opportunity and Administration Act established a nationwide marijuana excise tax of 10%, rising to 25% over five years.
Industry officials argued that the top rate in Schumer’s proposed bill not only would be onerous to operators but too high to reduce illicit operations.
Since then, Schumer’s group has collected comments on the draft, so the final version might look different.
https://mjbizdaily.com/key-us-house-panel-approves-marijuana-legalization-again/
Legalization is as simple as an executive order done in 24 hours time just like Nixon did it in 24 hours. There is huge money involved as prohibition is a CASH COW for states that will never ever legalize like Texas even though a majority of its tax payers desire that. Safe banking will automatically be just that with legalization.
Our government should stop pissing on people who prefer plants over pills and alcohol. But drinkers pass all laws so no weed smokers can work for our Government so America is weakened, only half strong. Amazon gets the fact weed smokers are smart and many do not drink. Who would be better to run the country drinkers like we have now or carl sagen types that like weed.
Chuck Schumer Says Key Senators Have ‘Agreement’ Not To Advance Marijuana Banking Reform Before Legalization.
Whether either proposal would be embraced by President Joe Biden if they were sent to his desk is yet to be seen, but Schumer said he’s going lobbying him “heavily” on legalization.
https://www.marijuanamoment.net/chuck-schumer-says-key-senators-have-agreement-not-to-advance-marijuana-banking-reform-before-legalization/
California-Grown Cannabis To Be Judged At Next State Fair. Stanley brothers grow any plants in Ca? Or how about a nationwide CBD judging edible bears, oils etc. scientifically like whats being done in Sacramento.
https://sacramento.cbslocal.com/2021/09/22/california-cannabis-state-fair/
“No, there won’t be a panel of judges sitting there smoking cannabis,” said Durfee.
Instead, each entry is sent to a laboratory and judged scientifically based on its chemical composition.
“We’re looking at seven different categories, two of them are cannabinoids and five of them are terpene profiles,” said Applegarth.
The state’s nearly 7,000 licensed cannabis cultivators are eligible to enter.
And just like wine and the others, the winner will be presented with the prestigious “golden bear” award, to acknowledge being the best the state has to offer.
“The goal is for cannabis to be celebrated in a very normalized way,” said Applegarth.
Winners will likely be able to showcase their cannabis plants, but marijuana won’t be available to sample, purchase or consume.
Now the prices are in line with higher content to make for stronger sales.
Charlotte's Web™ DAILY WELLNESS: Full-spectrum hemp extract with naturally occurring CBD supports everyday stress management, exercise recovery and sleep. Available in 15 milligrams (mg) or 25mg CBD strengths per serving, Daily Wellness comes in raspberry lime flavor with a suggested retail price (SRP) of $44.99 and $69.99, respectively.
Charlotte's Web™ THC-FREE: Broad-spectrum extract with naturally occurring CBD, with beneficial hemp phytocompounds and no trace of THC, supports everyday stress relief and relaxation, whether on the job or at home. Available in 15mg or 25mg CBD strengths per serving, THC-Free comes in mango peach flavor with a SRP of $44.99 and $69.99, respectively.
Charlotte's Web™ IMMUNITY: Full-spectrum hemp extract with naturally occurring CBD infused with 90mg of Vitamin C from organic acerola extract and 20 micrograms of Vitamin D3 from organic Astragalus root - the recommended daily intake of each vitamin for adults – supports a balanced immune system. With 10mg CBD strength per serving, Immunity comes in lemon berry flavor with a suggested retail price (SRP) of $44.99.
Hahahahahahahaha thanks for the good laugh in light of all going with new lows member marked you as the earth turns and burns, ozone zones, methane burps, we all look like her one day. In mean time weed partakers still are outlaws till some humans go extinct. Be probably all of us the burp big enough,,,, naw nukes get us first. Blow up the world before the U.N. will say weed is all right like were one of the kids. The Who said that.
FDA, politicians, fat, smart, and happy with money for sure all white people with more dough than all pizza pie shops on the east coast..
Well written new pertaining post from great veterans group hang with, We were all part of the war machine now outlaws in our own country cause would like Peace on Herb then the other peace on earth but cant cause the best weapons of mass destruction are made in USA and gots to be sold and keep countries wanting them, to fight including us no matter the made up reason. Money money money. All tax dollars to screw up the world with. In mean time no one can have weed. Go drink and pop pills the american way. The mexican way of smoking weed not allowed.
""""""END PROHIBITION... AGAIN."""""""
We are citizens who stand for peace, justice, and equal treatment under the law.
Devastation is the calling card of prohibition. Its disciples have been blinded by bigotry, and a rapacious lust for power which is impossible to quench. Backed by special interests, the drug war has left a scar across mother earth, deep and wide. The cornerstone of these endeavors is greed. The poster child of these injustices is cannabis.
In the United States, and subsequently across the globe, cannabis went from being a widely accepted traditional remedy, to being labeled a dangerous narcotic overnight - in historical contexts. This was done without any scientific evidence provided to support the assertions made by hardline activists, abusing their public offices and power. Citizens across our country have acknowledged the therapeutic potential of cannabis, as witnessed by their legal challenges, voter initiatives, and state legislation addressing the disparity between law and reality.
The federal status quo further aggravates hardships faced by all medical cannabis patients. Monopolizing patents, obstructing objective research, and working to subvert patient access to the healing properties of cannabis, are all themes played out time and again within the United States. This is not hyperbole. It is documented in myriad court cases spanning decades, leading right into the present moment. These difficulties include a lack of federal funding, a complex research approval process, and a shortage of government-approved cannabis for clinical trials.
These are some of the casualties of the government's declared war on cannabis: The disabled, the sick, and the dying.
We know cannabis has medical value, we are fed-up with bureaucratic efforts to block its medicinal use, and we are weary of those on the political margins - left and right - who advocate the cult of cultural warfare. Federal drug agencies within the United States have, of course, strongly resisted efforts to end the medical prohibition of cannabis.
It is likely these agencies will continue to agitate their clients in politics, law enforcement and the pharmaceutical sector to oppose such action. From our perspective, there is precious little political profit to be gained opposing compassion. Surely if physicians can be trusted to prescribe morphine, they can be trusted to employ cannabis in a safe, medically appropriate manner.
On the surface making cannabis legally available for medical purposes seems simple. As a natural substance, however, cannabis is not a “new drug.” Nor does it have a private pharmaceutical sponsor. Creating a rational system of prescriptive medical access encompasses complex regulatory and legal issues. There are also concrete concerns of appropriate governmental control over, and involvement in, programs of research, cultivation, manufacturing and distribution.
These questions require careful, public consideration. No one is advocating that all patients with cannabis-responsive disorders be forced to use cannabis. Ultimately the decision to employ any medication is a profoundly personal one which is best left to the patient and physician.
Federal cannabis reform is imminent, prohibition has failed again on a grand scale, and the world is ready for a fresh approach to public health, law, and criminal justice.
So mote it be.
-The Veterans Action Council
*Excerpts from the "Green Paper" were used for this article.
https://www.veteransactioncouncil.com/post/end-prohibition-again
I was buying last week at 2.30 still close enough..
Brian Osgood in Los Angeles
Mon, September 13, 2021, 5:45 AM
When Eugene Glover was released from prison in the summer of 2017 he believed he was starting a new chapter in his life, and leaving an old one behind him. After serving more than 14 years behind bars for a drug felony conviction, Glover moved into a halfway house and applied for food assistance.
If he could get some help covering food expenses, he reasoned, it would be one less thing to worry about as he set out to navigate the myriad challenges that come with rejoining society: housing, employment, rebuilding relationships with friends and family.
But when Glover applied for food assistance through the Supplemental Nutrition Assistance Program (Snap), colloquially known as food stamps, he received a notification from the Arizona department of economic security.
It was a message that unsettled his belief that the end of his sentence represented a clean break with his past: because his felony conviction was drug related, he was not eligible for Snap, and his claim had been denied. “I thought, wait a minute, I finished my sentence. Why am I still being punished?” said Glover. “You shouldn’t miss a meal because you were incarcerated or have a history of drug activity. That doesn’t seem right.”
Denying people food access is not a good way to approach re-entry
In 1996, a bill titled the Personal Responsibility and Work Opportunity Reconciliation Act, known simply as “welfare reform”, was signed into law by the former president Bill Clinton. It promised to tighten restrictions on welfare programs, making assistance leaner and more difficult to access.
The bill included a little-known provision known as Section 115 that imposed a lifetime ban on federal food and cash assistance for people with drug felony convictions. It was debated for only two minutes, but over the next several decades, the provision would have a devastating impact on formerly incarcerated people. In the five years after the bill passed, Section 115 resulted in more than 90,000 formerly incarcerated people being purged from welfare rolls.
There is little evidence that such restrictions deter criminal activity. A 2017 study by Crystal Yang at Harvard’s Olin Center found that access to welfare programs such as Snap decrease the likelihood of returning to prison during the first year of re-entry by 10%.
25 US states retain a version of Section 115
Food insecurity is common among formerly incarcerated people, who have a median income of just $10,000 a year and suffer from high levels of unemployment. A 2013 study by the National Institute of Health found that 91% experienced food insecurity upon re-entry. Some 37% reported having gone an entire day without food at least once in the previous month.
“When we talk about food justice in the legal system, it’s usually in the context of poor food options inside the prison system, and the many health problems that come with that,” said Kimberly Dong, an associate professor of public health and community medicine at Tufts University. “But because of these bans, those problems follow them into the outside world.”
Section 115 represented a political orthodoxy of the 1990s, when the war on drugs was raging, welfare use was heavily stigmatized through racialized attacks linking assistance to sloth and criminality, and policies that inflicted punishment on people with histories of drug activity were popular across the aisle.
Few politicians embodied the politics of that era more than Joe Biden, who authored the 1994 crime bill that targeted communities of color and put mass incarceration into overdrive, and lambasted “welfare mothers driving luxury cars” in a column he penned for the Newark Post in 1988.
In a change that reflects the country’s shifting political landscape and growing calls to reckon with the racist history of America’s criminal justice system, Biden now stands poised to roll back Section 115.
Both the American Families Plan (AFP), a centerpiece of the Biden administration’s legislative agenda focused on enhancing assistance to families, and Biden’s budget for 2022 would eliminate Section 115. In a statement from the Department of Agriculture, which oversees Snap, a spokesperson said that Section 115 “exacerbates inequities in communities that are disproportionately affected by incarceration due to structural racism in the criminal justice system”.
However, with such thin Democratic majorities in Congress, the prospects of the AFP passing is an open question.
In recent years, the momentum has been in the direction of moving away from the ban. Section 115 allowed states wide discretion over how they implemented the ban, and even allowed them to opt out altogether. Since 1996, 24 states, the Virgin Islands, and Washington DC have done so. Only one state, South Carolina, and the American territory of Guam, still have the full original ban on the books. But 25 states still have modified versions of the ban in place that erect numerous barriers for people with drug felony convictions trying to apply for Snap.
“There’s growing acknowledgment that denying people food access is not a good way to approach re-entry,” said Ed Bolen, a policy analyst with the Center on Budget and Policy Priorities. “It’s strictly punitive, and it exacerbates all the other challenges people face during re-entry.”
Thank you for posting. Is a matter of time as truth always wins. The plant is not a pill. FDA is in bed with you know who. So glad bought more shares last week. truth always wins in the end. In interim status quo rlues with boss hog biden hating on plants for why? Oh yeah his son the addict who died. That was not cannabis. Pill companies surely involved.
Biden a huge prohibitionist is whats holding sector back. Biden has always believed in incarceration and holding SNAP benefits back from all convicted felons. Biden co wrote this Bill Clinton signed into law. Saves Government food stamp money Pot felons deemed undeserving, while letting the Sacklers off with hand slap. Were it not for pills who would pay for drug TV commercials, biggest drug pushers in the world slide safe into home plate.
Biden Standing Firm On Cannabis Position So Far
While some in the industry had a degree of confidence as to what Biden may do if legislation ever reaches his desk, it appears now that just about anything is possible.
However, Biden is sticking to campaign promises about the plant and more recent press statements could provide an idea as to his potential actions.
On April 20, 2020, Biden press secretary Jen Psaki reiterated the President's support for states' rights, medical legalization and rescheduling cannabis as a Schedule II substance for additional research. Psaki also added that Biden's position did not align with the proposed bills in the House or Senate.
Though a commitment to campaign promises makes a candidate a more attractive choice, with public support growing and bipartisan backing gaining momentum, many people admit they can only theorize why Biden has stayed the course so far.
NORML political director Justin Strekal told Benzinga he wished he had an answer. "I have stories, but I don't have answers," Strekal said, adding that Biden's stance "defies political logic."
Brady Cobb, founder and former CEO of Bluma Wellness who has lobbied for cannabis reform on Capitol Hill, told Benzinga that he assumed there'd be "immediate alignment" under a Democrat President. "It's just not there," Cobb said, noting that the administration's early decision to fire staffers over cannabis use presented a confusing image that was pounced upon by the media.
Paul Blair, vice president of government affairs at Turning Point Brands (NYSE: TPB), said Biden's stance is "a start, but clearly not a present priority."
He added, "I don’t see the administration changing its stance, however, until they’re presented with a concrete consensus proposal for the regulation of the marketplace and a path to passage for a legalization bill." Blair said neither exist at the moment.
Others believe that confusion is at the heart of Biden's stance.
Ellen Mellody, a former spokesperson for Obama's 2008 press secretary, is now a strategist for the cannabis media firm MATTIO Communications. Mellody says Biden's reluctance is much like others of his generation who have been subject to waves of cannabis propaganda and misinformation though finds that to be a weak excuse.
"That's morally unconscionable, disappointing, out of line with this moral character and reveals how persuasive these misinformation campaigns have been surrounding cannabis," Mellody said.
As Psaki mentioned in April, Biden does not align with the current bills in either chamber of Congress. Cannabis operators note that reluctance around cannabis legalization is not exclusive to the President.
"Cannabis policy is an exceptionally contentious topic, which is exacerbated by legal, practical, social, racial, economic, commerce, public health and safety, states' rights, individual liberties, and internal trade and treaty-based complications," Trent Woloveck, chief commercial director of Jushi Holdings Inc. (OTC: JUSHF) told Benzinga, adding that pressing issues like COVID and the infrastructure take precedence but remains hopeful that cannabis reform will receive attention during this term.
Will Congress Pressure Biden With A Bill?
Some commended the reform efforts made by Democrats so far. Others were critical, noting fragmentation as a possible stumbling block.
https://finance.yahoo.com/news/biden-administration-going-move-cannabis-194618442.html
You locate cool articles. Yes lets get back on topic, classifying nature by race is subjective to do so with humans even more so.
Okay back on topic. Noticing the lack of short posts take that on the contrary being good for longs. Posts by shorts been missing for a spell. Would think would be more so many shares sold short, they all lurking for now? Or hedge funds dont lurk people do.
Thank you for your thoughtful thoughts. Is all about controlling the populace like you state. Defining humans by race does that. Hard to cease this practice. Barcodes,,, that was a good one!
Interesting thread going on thank you all for that. I think it's the fact humans are defined by race. If not,,, the word race and consequently racism would not exist.
Not defining humans by race, 'is it that important" where all people are simply people would be ideal.
How going forward should people be defined if not by race? Should we all be numbered instead.....
Why would a political party be against Gods Plant Cannabis? I know,,,, all have stock in piss test companies and industrial prisons profiting off others misery. 2, bust people for it and they cant vote so bust all non whites.
Despite a vote taken nine months ago to legalize marijuana, the drug still can't be purchased legally in South Dakota, with Gov. Kristi Noem being a staunch critic of legalization.
ASMA KHALID, HOST:
South Dakota voters surprised the country when they voted to legalize medical and recreational marijuana last November. But nine months later, South Dakotans still cannot purchase legal cannabis. One person standing in the way is Republican Governor Kristi Noem, who often markets her state as a home for freedom. South Dakota Public Broadcasting's Lee Strubinger has this report.
LEE STRUBINGER, BYLINE: Bill Stocker is not your typical marijuana reform advocate. He retired from both the Marine Corps and the Sioux Falls Police Department.
BILL STOCKER: I have 37 years in uniform. And I am a disabled veteran.
STRUBINGER: Stocker says law enforcement is stretched too thin, that it shouldn't be focused on marijuana. Instead, he says law enforcement should focus on heavily addictive drugs.
STOCKER: Fentanyl is the problem, not marijuana.
STRUBINGER: Stocker says that's why he supports marijuana legalization for South Dakotans and for himself.
STOCKER: I pay my taxes. I'm a registered voter. I do my due diligence. I'm a patriot. I have pain. I don't want to do opioids.
STRUBINGER: Stocker says the only thing that takes care of his pain is marijuana in the form of edibles. And he was counting on that after voters approved placing medical and recreational marijuana legalization into the state constitution, a cause he campaigned for.
But South Dakota Governor Kristi Noem, a nationally rising Republican star, has been resistant to cannabis reform since she took office, including opposing industrial hemp legalization during her first two years. Stocker voted for Noem when she ran for governor in 2018. And he says he's disappointed she's come between voters like him and marijuana legalization.
(SOUNDBITE OF ARCHIVED RECORDING)
KRISTI NOEM: I don't think anybody got smarter smoking pot.
STRUBINGER: And she's backing a lawsuit to overturn the voter-approved measure on constitutional grounds. The case is awaiting a state Supreme Court decision. Noem has said the state's voters made a bad decision when approving the constitutional amendment. But a majority of Americans are not on Noem's side. According to a recent Pew Research survey, 60% of Americans say marijuana should be legal for medical and recreational use.
(SOUNDBITE OF ARCHIVED RECORDING)
CHUCK SCHUMER: Even South Dakota, one of the most conservative states in America - a majority voted to legalize adult recreational use of marijuana.
STRUBINGER: That national support is something that U.S. Senate Majority Leader Chuck Schumer hopes to capitalize on. He's pushing to decriminalize marijuana at the federal level.
(SOUNDBITE OF ARCHIVED RECORDING)
SCHUMER: If South Dakota can do it, the Senate should be able to do it.
STRUBINGER: Fifty-five percent of South Dakota voters voted in favor of legalizing recreational pot in 2020. In 2018, it was just 51% of voters who voted to elect Kristi Noem for governor. A lot has changed since she first ran, including her increased stature following her hands-off approach to the coronavirus pandemic. Noem has lost at least one vote in retired police officer Bill Stocker.
STOCKER: I will not vote for her. Matter of fact, if there is a good candidate running against her in '22, I will not only support that candidate. I will actively campaign for that candidate.
STRUBINGER: No one has announced a challenge to Governor Noem yet. But it's safe to assume cannabis will be a major part of their platform. For NPR News, I'm Lee Strubinger in Rapid City.
https://www.npr.org/2021/08/29/1032169524/south-dakota-residents-still-cant-buy-marijuana
Joe Biden Can No Longer Hide From Cannabis Legalization Efforts
Cannabis legalization efforts in Congress have been a series of hits and misses during the Joe Biden administration, even as Congress juggles more cannabis-related bills than ever before. There are currently 35 cannabis-related bills in Congress—26 in the House, nine in the Senate.
The foot-dragging on cannabis legalization wasn’t the plan when Biden got elected. Many industry stakeholders expected a slam dunk on legalization when he took office.
The pre-election thinking was that Biden and Vice President Kamala Harris would finally take cannabis off the DEA’s Schedule I list, open up banking, fix disparities in the cannabis business environment so that everyone could get a piece of the pie, and end the war on drugs for good.
Well, it hasn’t quite worked out that way... yet.
The Biden Hope
When the Biden administration took over in January 2021, there was the expectation that legalization efforts in Congress would accelerate. After all, Harris admitted to smoking cannabis during a radio interview in February 2019 (“It gives a lot of people joy. And we need more joy in the world.”).
An article in Forbes magazine in August 2020 written by the president of an investment and operations firm in the legal cannabis industry, Kris Krane, appeared to double-down on Harris’s influence: “If elected Vice President, she is arguably reformers’ best hope of moving Joe Biden and the Democratic Party towards a position of full support for cannabis legalization.”
Harris is also the co-sponsor of the Marijuana Justice Act of 2019 (S597), which has gained no traction in Congress; she is the lead sponsor of the Marijuana Opportunity, Reinvestment and Expungement Act (The MORE Act, HR3884), considered one of the most comprehensive cannabis legalization bills passed by the House in December 2020 (five Republicans voted in favor of the bill) that was recently re-introduced in the House; and she was the co-sponsor of the original Secure and Fair Enforcement Banking Act (the SAFE Banking Act, HR1996), which passed in the House in April, 2021 and now sits in the Senate. That bill enjoys the bipartisan support of 180 co-sponsors in Congress.
Both Harris and Biden have evolved their thinking about cannabis legalization in a good way over the years.
Before being elected senator in 2016, Harris oversaw over 1,900 cannabis convictions as the San Francisco district attorney.
Biden, as senator and head of the Senate Judiciary Committee in the late ‘80s and early ‘90s, helped craft plans for the war on drugs, calling for an escalation of what President H.W. Bush had proposed in September 1989: “Quite frankly, the president’s plan is not tough enough, bold enough, or imaginative enough to meet the crisis at hand,” Biden said then.
Flash forward to the 2020 election. Candidate Biden’s justice plan echoed what cannabis advocates had been saying as put forward in the MORE Act: “No one should be incarcerated for drug use alone. Instead, they should be diverted to drug courts and treatment.”
Naturally, cannabis advocates were confused when the newly-elected Biden promptly demoted or fired White House staff for admitting to past cannabis use. Why cling to reefer madness?
Legalization Gets New Life
The legalization issue keeps showing up in different ways.
On December 21, 2020, Congress passed a Covid-19 stimulus package that included repealing the prohibition on students with drug convictions from receiving federal financial aid, helping thousands of students get an education.
Then in July 2021, Senate Majority Leader Chuck Schumer (D-NY), Senator Cory Booker (D-NJ) and Senate Finance Committee Chairman Ron Wyden (D-OR) unveiled a draft of a new bill, “Cannabis Administration and Opportunity Act,” a “thoughtful, comprehensive approach” to federal cannabis reform, according to the National Cannabis Roundtable.
The draft of the bill, actually a “discussion draft,” reads like a slightly revised MORE Act. But it is the first time a Senate majority leader has sponsored a cannabis legalization bill. And Schumer told Politico that there would be a floor vote on the bill, which would be the first time that the Senate has held such a vote on descheduling cannabis.
The Reality in Congress
With Democrats in charge of Congress, it would still take 10 Republican senators and all Democratic senators to pass a cannabis legalization bill. Schumer’s bill, in whatever form it eventually takes, will likely not have enough votes to pass.
Viridian Capital Advisors, a strategic cannabis capital advisory company, saw it this way: “Beyond symbolic factors, we believe the impact of Mr. Schumer’s draft will be largely immaterial as the bill is unlikely to pass in its current state or even in a significantly pared down version.”
The Biden administration was also less than encouraging. “Nothing has changed, and there’s no new endorsements of legislation to report today,” Press Secretary Jen Psaki said when asked about Schumer’s bill.
In a previous press conference, Psaki said that Biden supports leaving decisions regarding legalization for recreational use up to the states; supports legalizing medical marijuana; rescheduling cannabis as a Schedule II drug so researchers can study its positive and negative impacts; and, at the federal level, supporting decriminalizing marijuana use and automatically expunging any prior criminal records.
That’s not the last word on Schumer’s bill, because the need for such a bill is not going away, in part because new events keep creating more discussion.
New Spotlights
The discrepancies between anti-cannabis laws and the societal shift in favor of cannabis continue to take public stage.
For example, the White House wants to meet with the World Anti-Doping Agency (WADA) sometime before the end of November about loosening the restrictions on the use of cannabis by athletes following the suspension from the 2021 Olympic team of 100 meter track star Sha’Carri Richardson by the United States Anti-Doping Agency (USADA). Richardson tested positive for cannabis in Oregon, where adult-use cannabis consumption is legal.
“The rules are the rules,” Biden told CBS reporter Bo Erickson. “And everyone knows what the rules were going in. Whether they should remain that way is a different issue.”
In a letter to WADA about the ruling co-authored by Rep. Alexandria Ocasio-Cortez (D-NY), the vice chair of the Subcommittee on Civil Rights and Liberties, and Rep. Jamie Raskin (D-MD), chair of that same committee, the ban on cannabis was called “a significant and unnecessary burden on athletes’ civil liberties.”
Harris later tweeted: “Their (WADA) decision lacks any scientific basis. It's rooted solely in the systemic racism that's long driven anti-marijuana laws.”
Nearly 600,000 people have signed a petition to reinstate Richardson as of this reporting.
And the Drug Enforcement Administration (DEA) is stepping up licensing more legal cannabis grows for medical research, a significant move because, since 1968, there has been only one place (a farm on the University of Mississippi) where legal cannabis for research can be grown.
Critical Mass?
Are we approaching critical mass on legalization? If we are, it’s coming about as a result of basic cannabis legalization issues that have had their moments on the global stage—such as decriminalization, medical research and wrongful incarceration.
Even the highest court in the land appears to be changing direction on cannabis legalization.
In his confirmation hearing February 22, attorney general nominee Merrick Garland affirmed decriminalization as a goal: “We can focus our attention on violent crimes and other crimes that put great danger in our society and not allocate our resources to something like marijuana possession.”
In late June, in an opinion about the merits of a Colorado medical dispensary case regarding the constitutionality of taxes as related to the cost of goods sold, Supreme Court Justice Clarence Thomas captured the absurdity of legalization. He wrote that the federal government’s current approach is a half-in, half-out regime that “simultaneously tolerates and forbids local use of marijuana. This contradictory and unstable state of affairs strains basic principles of federalism and conceals traps for the unwary.”
He concludes: “A prohibition on intrastate use or cultivation of marijuana may no longer be necessary or proper to support the Federal Government’s piecemeal approach.”
The U.S. Surgeon General Vivek Murthy recently added his voice to that particular chorus during an interview on CNN’s “State of the Union”: “When it comes to decriminalization, I don’t think that there is value to individuals or to society to lock people up for marijuana use. I don’t think that serves anybody well.”
All Aboard
So here we are with President Biden, Vice President Harris, Attorney General Garland, Surgeon General Murthy, Supreme Court Justice Thomas, hundreds of members of Congress including the Senate Majority leader, the DEA—all on board promoting the need for cannabis legalization in some form... a substance the DEA still lists in the same category as heroin.
Beyond absurd? Of course.
It's especially absurd when you consider the racists roots of cannabis prohibition from Anslinger to Nixon.
Meanwhile, with 10 newly legalized states scheduled to begin selling cannabis in 2021 or 2022, the legal market is projected at reaching $43 billion by 2025, according to data from New Frontier, a cannabis analytical service.
The big question no one can answer about federal legalization in the U.S. is: When?
https://www.yahoo.com/now/joe-biden-no-longer-hide-230112670.html
Fresh news.
A federal appeals court has dismissed a petition to require the Drug Enforcement Administration (DEA) to reevaluate marijuana’s scheduling under the Controlled Substances Act (CSA)—but one judge said in a concurring opinion that the agency may soon be forced to consider a policy change anyway based on a misinterpretation of the medical value of cannabis.
In a ruling filed on Monday, the U.S. Court of Appeals for the Ninth Circuit determined that scientists and military veterans seeking the scheduling review had failed to exhaust administrative remedies, and, therefore, it dismissed the case without weighing in on the merits.
The lawsuit—filed last year by cannabis researcher Sue Sisley of the Scottsdale Research Institute, the Battlefield Foundation and veterans Lorenzo Sullivan and Gary Hess—received oral arguments in June and largely centers on DEA’s 2020 denial of a one-page marijuana rescheduling petition filed by a separate individual. In its response, the agency argued that marijuana has no currently accepted medical value.
Lawyers for the group appealed that decision, asking the court to order DEA to initiate a formal rulemaking process, which would involve expert testimony and public comment. They said that the agency’s summary dismissal of past rescheduling petitions has not only been unconstitutional but also prevented important research into the drug’s medical potential.
But in the new ruling, the three-judge panel held that “petitioners failed to exhaust their administrative remedies with the DEA.” And while “the CSA does not, in terms, require exhaustion of administrative remedies, the panel agreed with [an earlier court ruling] that the text and structure of the CSA show that Congress sought to favor administrative decision-making that required exhaustion under the CSA,” the opinion says.
“Petitioners seek to bypass the normal administrative process by seeking review of the DEA’s response to [Stephen Zyszkiewicz’s] petition and then seeking to make arguments never advanced by Zyszkiewicz. Nothing prevents Petitioners from filing a petition of their own before the DEA, raising the arguments they seek to raise before us now. Because Petitioners have failed to exhaust their administrative remedies with the DEA, their petition for judicial review is dismissed.”
The Ninth Circuit judges did reject a DEA argument that the plaintiffs lacked standing based on the fact that they were petitioning a rescheduling request filed separately by someone who wasn’t party to the latest suit and only suffered a “generalized grievance,” however.
“While it is undoubtedly true that the interests of third parties would be affected by a rescheduling of cannabis, this fact does not diminish Petitioners’ direct and particularized interest in rescheduling,” the panel found.
Moving forward, attorneys for the plaintiffs have a number of options at their disposal. That includes petitioning for a panel rehearing or even an appeal to the U.S. Supreme Court.
The petitioners initially filed their lawsuit, Sisley v. DEA, against the federal agency in May of last year, contending that DEA’s justification for maintaining a Schedule I status for cannabis violates the Constitution on numerous grounds. DEA attempted to dismiss the case, but the Ninth Circuit rejected that request in August.
Justice Department lawyer Daniel Aguilar, who represented the federal government at the oral argument in June, insisted that the court should dismiss the case and allow the group to file their own DEA rescheduling petition.
Judges Paul Watford concurred with the latest ruling, but he did notably say in a concurring opinion that, “in an appropriate case, the Drug Enforcement Administration may well be obliged to initiate a reclassification proceeding for marijuana, given the strength of petitioners’ arguments that the agency has misinterpreted the controlling statute by concluding that marijuana ‘has no currently accepted medical use in treatment in the United States.'”
Sisley, the lawsuit’s lead plaintiff and president of the Scottsdale Research Institute (SRI), is a DEA-licensed researcher focused on investigating the therapeutic potential of cannabis for veterans. She’s sought to become a federally authorized marijuana manufacturer so that her facility can produce higher quality products for studies.
SRI has already taken the feds to court over past marijuana decisions, with results to show for it. The institute successfully forced DEA to issue an update on the status of their application processing and then got the Justice Department to hand over a “secret” memo that DEA allegedly used to justify a delay in deciding those proposals.
In May, Sisley and SRI received preliminary approval from DEA to be one of the first new federally authorized cultivators of cannabis for research.
Read the full Ninth Circuit ruling in the DEA marijuana case below:
https://www.marijuanamoment.net/court-dismisses-dea-marijuana-rescheduling-case-but-judge-says-cannabis-reclassification-may-be-coming-anyway/
If believe in the products, if you think the more act and others will be passed go and buy. Knowing the new Gov on New York is balls to the walls with legalization in her home state go and buy, Coumo was a foot dragger in this regard.
Bought a bunch yesterday now have average cost per share thats better at 3.44
Who knows, all can do is go with gut no one is ringing a bell saying buy. Takes courage or lack of brains when fear is in the streets stock near lows.
Have fun is all, The world is on fire in interim, the Earth being destroyed, the ice caps melting. Polar bears are suffering worse than the web and will go extinct soon. This stock will survive all this or burn up like lake tahoe and Siberia's tundra.
Don't know about any dead cats that bounce with rigamortis and all. This here is a spider with tangled webs,
Well in spite of all negativity which won't last forever as cbd is for real, just bought more shares ten minutes ago bringing dollar cost average down to 3.25 or so.
Never thought would have opportunity to get more near 52 week lows bringing average way on down. Should be good to go.......... Stock is not what used to be. That can change on a turn style.
With a humongous increase in volume the preferred way to head north coupled with change in regs..
When Fools come out with weekend article to do not buy trying to get a new low out of it is the time to buy.
3 Cannabis Stocks to Avoid Now
Pot stocks are a big growth opportunity, but not for these three, at least not yet.
Aug 28, 2021 at 7:45AM
https://www.fool.com/investing/2021/08/28/3-cannabis-stocks-to-avoid-now/
This CBD stock isn't what it used to be
Alex Carchidi (Charlotte's Web Holdings): Sometimes, it's best to avoid a company that isn't getting much from its leadership position in a market.
On that note, Charlotte's Web makes a smattering of wellness products for humans and pets, all of which contain cannabidiol (CBD), a chemical derived from cannabis. Whereas typical cannabis goods might be inebriating, CBD isn't, and proponents claim that it has beneficial effects, like reducing anxiety. So the market for CBD isn't the same as the burgeoning markets for medicinal and recreational cannabis, though there is probably some overlap.
Per the company's latest earnings report, second-quarter revenue only grew by 11.4% year over year to reach $24.2 million, which is far too low for a relatively small business that investors might look to for robust growth. And quarterly revenue seems to have stagnated after 2019, when it brought in $25 million in the second quarter.
On top of this slowing demand, profitability has remained out of reach for the last two years. That was doubtlessly caused by sharp rises in Charlotte's Web's cost of goods sold (COGS) and its selling, general, and administrative (SG&A) expenses since 2018. At least some of the increased SG&A expenditures stem from growing its marketing channels and spending to maintain and expand its leading market share in several distribution segments. In 2020, Charlotte's Web was the largest CBD pure-play competitor in e-commerce, food stores, drugstores, natural specialty retail, and mass retail.
Still, being the top dog in these segments of the CBD market hasn't led to significant revenue growth or significant returns for investors over the last few years. So investors should steer clear of this stock until management demonstrates that the company's leading market share is actually beneficial to shareholders.
Cool! Best case scenario is when covering starts by some on the way back up, others average up their short positions over and over in denial. When these people or robots cover when good and STUCK who knows where the share price will be.
In all things Cannabis I Trust.